Post-transplant Lymphoproliferative Disorder View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2009-11-27

AUTHORS

Ran Reshef , Alicia K. Morgans , Donald E. Tsai

ABSTRACT

The increased risk of malignancy, especially of lymphoid tumors, in solid-organ and hematopoietic stem cell transplant (HST) recipients has been recognized for many years [1-3]. Post-transplant lymphoproliferative disorder (PTLD) represents a heterogeneous group of abnormal lymphoid proliferations, generally of B-cell origin, that occur in the setting of ineffective T-cell function due to pharmacologic immunosuppression after organ transplantation. Unlike most other forms of non-Hodgkin’s lymphoma, nearly all PTLD is associated with Epstein-Barr virus (EBV) infection, as manifested by the presence of EBV within the malignant tissue. More... »

PAGES

597-618

Book

TITLE

Allogeneic Stem Cell Transplantation

ISBN

978-1-934115-33-6
978-1-59745-478-0

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-59745-478-0_34

DOI

http://dx.doi.org/10.1007/978-1-59745-478-0_34

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020989826


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reshef", 
        "givenName": "Ran", 
        "id": "sg:person.01267452463.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morgans", 
        "givenName": "Alicia K.", 
        "id": "sg:person.01344577704.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344577704.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsai", 
        "givenName": "Donald E.", 
        "id": "sg:person.012706202757.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2009-11-27", 
    "datePublishedReg": "2009-11-27", 
    "description": "The increased risk of malignancy, especially of lymphoid tumors, in solid-organ and hematopoietic stem cell transplant (HST) recipients has been recognized for many years [1-3]. Post-transplant lymphoproliferative disorder (PTLD) represents a heterogeneous group of abnormal lymphoid proliferations, generally of B-cell origin, that occur in the setting of ineffective T-cell function due to pharmacologic immunosuppression after organ transplantation. Unlike most other forms of non-Hodgkin\u2019s lymphoma, nearly all PTLD is associated with Epstein-Barr virus (EBV) infection, as manifested by the presence of EBV within the malignant tissue.", 
    "editor": [
      {
        "familyName": "Lazarus", 
        "givenName": "Hillard M.", 
        "type": "Person"
      }, 
      {
        "familyName": "Laughlin", 
        "givenName": "Mary J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-59745-478-0_34", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-934115-33-6", 
        "978-1-59745-478-0"
      ], 
      "name": "Allogeneic Stem Cell Transplantation", 
      "type": "Book"
    }, 
    "keywords": [
      "post-transplant lymphoproliferative disorder", 
      "lymphoproliferative disorders", 
      "hematopoietic stem cell transplant recipients", 
      "Epstein-Barr virus infection", 
      "stem cell transplant recipients", 
      "abnormal lymphoid proliferations", 
      "cell transplant recipients", 
      "presence of EBV", 
      "risk of malignancy", 
      "transplant recipients", 
      "pharmacologic immunosuppression", 
      "Hodgkin's lymphoma", 
      "lymphoid proliferations", 
      "organ transplantation", 
      "virus infection", 
      "lymphoid tumors", 
      "cell origin", 
      "malignant tissues", 
      "heterogeneous group", 
      "cell function", 
      "lymphoma", 
      "disorders", 
      "immunosuppression", 
      "transplantation", 
      "malignancy", 
      "tumors", 
      "EBV", 
      "infection", 
      "recipients", 
      "risk", 
      "proliferation", 
      "tissue", 
      "group", 
      "years", 
      "setting", 
      "presence", 
      "function", 
      "origin", 
      "form"
    ], 
    "name": "Post-transplant Lymphoproliferative Disorder", 
    "pagination": "597-618", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020989826"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-59745-478-0_34"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-59745-478-0_34", 
      "https://app.dimensions.ai/details/publication/pub.1020989826"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-12-01T20:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/chapter/chapter_327.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-59745-478-0_34"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-59745-478-0_34'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-59745-478-0_34'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-59745-478-0_34'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-59745-478-0_34'


 

This table displays all metadata directly associated to this object as RDF triples.

118 TRIPLES      23 PREDICATES      64 URIs      57 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-59745-478-0_34 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nf4a7fbf1ea0b430b90c971ed3f643c5b
4 schema:datePublished 2009-11-27
5 schema:datePublishedReg 2009-11-27
6 schema:description The increased risk of malignancy, especially of lymphoid tumors, in solid-organ and hematopoietic stem cell transplant (HST) recipients has been recognized for many years [1-3]. Post-transplant lymphoproliferative disorder (PTLD) represents a heterogeneous group of abnormal lymphoid proliferations, generally of B-cell origin, that occur in the setting of ineffective T-cell function due to pharmacologic immunosuppression after organ transplantation. Unlike most other forms of non-Hodgkin’s lymphoma, nearly all PTLD is associated with Epstein-Barr virus (EBV) infection, as manifested by the presence of EBV within the malignant tissue.
7 schema:editor Nf480354b39314161909b2cfe8a9c15cf
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N6ef2b3e225b84014b3e6319c0d4bf4aa
12 schema:keywords EBV
13 Epstein-Barr virus infection
14 Hodgkin's lymphoma
15 abnormal lymphoid proliferations
16 cell function
17 cell origin
18 cell transplant recipients
19 disorders
20 form
21 function
22 group
23 hematopoietic stem cell transplant recipients
24 heterogeneous group
25 immunosuppression
26 infection
27 lymphoid proliferations
28 lymphoid tumors
29 lymphoma
30 lymphoproliferative disorders
31 malignancy
32 malignant tissues
33 organ transplantation
34 origin
35 pharmacologic immunosuppression
36 post-transplant lymphoproliferative disorder
37 presence
38 presence of EBV
39 proliferation
40 recipients
41 risk
42 risk of malignancy
43 setting
44 stem cell transplant recipients
45 tissue
46 transplant recipients
47 transplantation
48 tumors
49 virus infection
50 years
51 schema:name Post-transplant Lymphoproliferative Disorder
52 schema:pagination 597-618
53 schema:productId N0b8a091a61c34bf4a2c20d4cbf21ab02
54 N4a577ddb32c7404aad3c5ea599a48909
55 schema:publisher Nc123c0caaccb409cb9d1e6a2cb212593
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020989826
57 https://doi.org/10.1007/978-1-59745-478-0_34
58 schema:sdDatePublished 2021-12-01T20:05
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N01cb1f38d4fa421fa8c29d1514ce91b9
61 schema:url https://doi.org/10.1007/978-1-59745-478-0_34
62 sgo:license sg:explorer/license/
63 sgo:sdDataset chapters
64 rdf:type schema:Chapter
65 N01cb1f38d4fa421fa8c29d1514ce91b9 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N0b8a091a61c34bf4a2c20d4cbf21ab02 schema:name doi
68 schema:value 10.1007/978-1-59745-478-0_34
69 rdf:type schema:PropertyValue
70 N4a577ddb32c7404aad3c5ea599a48909 schema:name dimensions_id
71 schema:value pub.1020989826
72 rdf:type schema:PropertyValue
73 N6ef2b3e225b84014b3e6319c0d4bf4aa schema:isbn 978-1-59745-478-0
74 978-1-934115-33-6
75 schema:name Allogeneic Stem Cell Transplantation
76 rdf:type schema:Book
77 N6f0d25e125fe4d1198257cd11646ab0b schema:familyName Laughlin
78 schema:givenName Mary J.
79 rdf:type schema:Person
80 N7f47198df84c4851a308ebb3d5911751 schema:familyName Lazarus
81 schema:givenName Hillard M.
82 rdf:type schema:Person
83 N88835cce0a91468cb12564c087b16189 rdf:first sg:person.012706202757.24
84 rdf:rest rdf:nil
85 Nc123c0caaccb409cb9d1e6a2cb212593 schema:name Springer Nature
86 rdf:type schema:Organisation
87 Nd11631ab37914c28b6e9413494d9b05a rdf:first N6f0d25e125fe4d1198257cd11646ab0b
88 rdf:rest rdf:nil
89 Ne722712fe53b43aeb6a79dd7a1b014ca rdf:first sg:person.01344577704.60
90 rdf:rest N88835cce0a91468cb12564c087b16189
91 Nf480354b39314161909b2cfe8a9c15cf rdf:first N7f47198df84c4851a308ebb3d5911751
92 rdf:rest Nd11631ab37914c28b6e9413494d9b05a
93 Nf4a7fbf1ea0b430b90c971ed3f643c5b rdf:first sg:person.01267452463.62
94 rdf:rest Ne722712fe53b43aeb6a79dd7a1b014ca
95 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
96 schema:name Medical and Health Sciences
97 rdf:type schema:DefinedTerm
98 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
99 schema:name Immunology
100 rdf:type schema:DefinedTerm
101 sg:person.01267452463.62 schema:affiliation grid-institutes:grid.412713.2
102 schema:familyName Reshef
103 schema:givenName Ran
104 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62
105 rdf:type schema:Person
106 sg:person.012706202757.24 schema:affiliation grid-institutes:grid.412713.2
107 schema:familyName Tsai
108 schema:givenName Donald E.
109 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24
110 rdf:type schema:Person
111 sg:person.01344577704.60 schema:affiliation grid-institutes:grid.412713.2
112 schema:familyName Morgans
113 schema:givenName Alicia K.
114 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344577704.60
115 rdf:type schema:Person
116 grid-institutes:grid.412713.2 schema:alternateName Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA
117 schema:name Abramson Cancer Center, Hematologic Malignancies Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA
118 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...